BioVie prices $4.74 million registered direct offering at $1.60 a share
BIVI•BioVie priced a $4.74 million registered direct offering of 2,962,500 shares or common stock equivalents at $1.60 each. It also plans a private placement of warrants for up to 2,962,500 shares, with closing expected on or about November 5, 2026.
1. Offering terms
BioVie priced a registered direct offering of 2,962,500 common shares or common stock equivalents at $1.60 each, for expected gross proceeds of approximately $4.74 million. A concurrent private placement includes unregistered warrants to purchase up to 2,962,500 common shares at $1.70 per share.
2. Warrant details
The warrants become exercisable six months after issuance and expire five and a half years from issuance. The offering is expected to close on or about November 5, 2026, subject to customary conditions. Net proceeds will fund working capital and general corporate purposes.
